Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ADELINE E ABAM

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1902277056
CMS profile
11029630
Location
FORT WORTH, TX

General Payments · PY2021–2024

$916.94

  • Reported across 37 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$643.99

31 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $643.99 31

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $258.41 16
Indivior Inc. $116.11 5
Janssen Pharmaceuticals, Inc $114.44 3
Otsuka America Pharmaceutical, Inc. $82.90 4
ABBVIE INC. $28.87 1
Alkermes, Inc. $26.79 1
Supernus Pharmaceuticals, Inc. $16.47 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $100.03 1
PY2023 $172.92 5
PY2024 $643.99 31

Payment records · PY2024 (31)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20212023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $28.87 09/09/2024 Food and Beverage Undisputed 01/23/2026 1106403333 CMS
Alkermes, Inc. $26.79 10/15/2024 Food and Beverage Undisputed 01/23/2026 1120452534 CMS
Indivior Inc. $23.51 01/22/2024 Food and Beverage Undisputed 01/23/2026 1144541315 CMS
Indivior Inc. $22.84 04/18/2024 Food and Beverage Undisputed 01/23/2026 1144541317 CMS
Indivior Inc. $20.81 05/07/2024 Food and Beverage Undisputed 01/23/2026 1144541319 CMS
Indivior Inc. $25.10 05/16/2024 Food and Beverage Undisputed 01/23/2026 1144541321 CMS
Indivior Inc. $23.85 06/13/2024 Food and Beverage Undisputed 01/23/2026 1144541323 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.12 05/16/2024 Food and Beverage Undisputed 01/23/2026 1143350677 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.55 06/20/2024 Food and Beverage Undisputed 01/23/2026 1143350681 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.65 06/27/2024 Food and Beverage Undisputed 01/23/2026 1143350685 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.89 07/23/2024 Food and Beverage Undisputed 01/23/2026 1143350689 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.46 08/01/2024 Food and Beverage Undisputed 01/23/2026 1143350693 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $10.64 08/29/2024 Food and Beverage Undisputed 01/23/2026 1143350696 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4.68 08/30/2024 Food and Beverage Undisputed 01/23/2026 1143350700 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.21 10/03/2024 Food and Beverage Undisputed 01/23/2026 1143350704 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2.74 10/03/2024 Food and Beverage Undisputed 01/23/2026 1143350707 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.51 10/17/2024 Food and Beverage Undisputed 01/23/2026 1143350711 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.17 11/07/2024 Food and Beverage Undisputed 01/23/2026 1143350715 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.31 11/13/2024 Food and Beverage Undisputed 01/23/2026 1143350719 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.32 11/21/2024 Food and Beverage Undisputed 01/23/2026 1143350722 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.26 11/26/2024 Food and Beverage Undisputed 01/23/2026 1143350726 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.64 12/03/2024 Food and Beverage Undisputed 01/23/2026 1143350729 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $26.26 12/17/2024 Food and Beverage Undisputed 01/23/2026 1143350733 CMS
Janssen Pharmaceuticals, Inc $28.09 08/26/2024 Food and Beverage Undisputed 01/23/2026 1078200869 CMS
Janssen Pharmaceuticals, Inc $69.20 09/11/2024 Food and Beverage Undisputed 01/23/2026 1078200147 CMS
Janssen Pharmaceuticals, Inc $17.15 12/05/2024 Food and Beverage Undisputed 01/23/2026 1078199849 CMS
Otsuka America Pharmaceutical, Inc. $19.35 09/20/2024 Food and Beverage Undisputed 01/23/2026 1119010077 CMS
Otsuka America Pharmaceutical, Inc. $24.95 10/08/2024 Food and Beverage Undisputed 01/23/2026 1119010079 CMS
Otsuka America Pharmaceutical, Inc. $15.17 10/31/2024 Food and Beverage Undisputed 01/23/2026 1119010081 CMS
Otsuka America Pharmaceutical, Inc. $23.43 11/14/2024 Food and Beverage Undisputed 01/23/2026 1119010083 CMS
Supernus Pharmaceuticals, Inc. $16.47 08/07/2024 Food and Beverage Undisputed 01/23/2026 1147862897 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.